The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

BACKGROUND: Previous studies have demonstrated the benefits of thymosin alpha-1 (Tα1) in anti-virus, immunological enhancement and anti-inflammation. However, it is controversial about the efficacy and safety of entecavir (ETV) plus Tα1 combination therapy versus ETV monotherapy in cirrhotic patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Dan, Xing, Hai-Yan, Li, Chen, Wang, Xian-Feng, Hou, Min, Li, Bin, Chen, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574490/
https://www.ncbi.nlm.nih.gov/pubmed/33076834
http://dx.doi.org/10.1186/s12876-020-01477-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574490/
https://www.ncbi.nlm.nih.gov/pubmed/33076834
http://dx.doi.org/10.1186/s12876-020-01477-8

Ejemplares similares